The trial for severe-to-critical Covid-19 patients

The trial for severe-to-critical Covid-19 patients, which costs about $9 million, has recruited 247 of its targeted 390 patients, Pourhassan said. The FDA has agreed to review its efficacy results at the 75% recruitment point, which could be hit as soon as next week, Seethamraju said."

46 new patients in one week? Has Dr S been infected by NP's acute unrealistic timeline syndrome or is it for real?